Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the CoronavirusOvertaxed healthcare systems will delay enrollment in some geographic locations - BioSpace

Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the CoronavirusOvertaxed healthcare systems will delay enrollment in some geographic locations  BioSpace